Center for Access & Delivery Research and Evaluation Center of Innovation in the Iowa City VA Health Care System. Tweets don't necessarily represent those of VA
CARRIAGE II--a 4-year, $3.2M VA #QUERI project led by @eliowa--aims to target the growing threats of antimicrobial resistance and emerging infectious diseases. This sequel to CARRIAGE will also include increased focus on mentorship & implementation.
https://t.co/RydqlzPdPF
September In Progress issue released: HSR&D funds several Centers, QUERI programs, and research studies devoted to Helping Veterans Cope with and Conquer Pain. https://t.co/1Dd2uTgchA
A new study led by Michael Ohl, MD, finds that remdesivir, the first new medicine approved for treatment of #COVID19, has little impact on survival and increase hospital stays for patients. Learn more about the remdesivir study: https://t.co/od0RetVwxc #CCOM#UIResearch
It was a pleasure to present with fellow @va_vccore investigators Dr. Haderlein of @VA_CSHIIP and Dr. O'Shea of @IC_CADRE on our #telehealth research during a national @vahsrd cyberseminar!
You can access the recording here ⬇️⬇️
https://t.co/7kM8bKHSjD
Remdesivir treatment was not associated w/survival but was associated w/longer hospitalization. Does routine use lead to use of hospital beds w/out leading to clear improvement in patient survival? New work from @VA_CHOIR & @IC_CADRE in @JAMANetwork.
https://t.co/aPnQezKhhT
The @AcademyHealth ARM begins on Monday, 6/14 and VA HSR&D is well-represented. Loads of great sessions & work will be presented. Check out the updated VA sessions flyer for details!
Michael Ohl's study featured in the CDC Intervention Research Compendium - see below! 👏
Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention Care: HIV Telehealth in Veterans Administration Clinics ⬇️
https://t.co/GjatgCHxRy
New work from B Lund w/@IC_CADRE RE: medication-assisted treatment for OUD. Providers should consider whether buprenorphine pharmacotherapy, whether intermittent or continuous, could provide health benefits & prevent mortality. @AmJPrevMed
https://t.co/E7sDZuwSEJ
National #VAResearchWeek is May 17-21! #VAResearch has been working to improve the lives of #veterans and all Americans for over 95 years. Save the Date as we recognize their innovative efforts: https://t.co/L3f4i8tlzC
An @IC_CADRE-led retrospective analysis of ~4300 smokers in #COPDGene data from @nicholasrarnold, @FortisSpyridon published in @respcare. 🗝: Diagnosis and treatment of obstructive lung disease possible even before lung function becomes abnormal. https://t.co/lOL5z3zPs8
New Article:
Successful Multimodal Measures Preventing COVID-19 Outbreaks Without Universal Frequent Testing within Long-Term Care Units in the Midwestern Veterans Health Care Network
Contribution by Eli Perencevich, MD MS and Michihiko Goto, MD MS
https://t.co/rCiy4Imusx
An upcoming publication in @ICHEJournal from @MGoto_Iowa & @eliowa reveal ZERO #COVID19 infections in nearly 500 #LTC residents across six months. A variety of prevention measures implemented at multiple sites make the difference. @VAIowaCity@vahsrd https://t.co/UjP8CoRvSS
With a new @AHRQNews K08, @MGoto_Iowa will study the current use of antibiograms and work to develop a more adaptive "smart antibiogram" that incorporates informatics and prediction modeling to reduce GNR pathogen resistance. Congratulations!
https://t.co/wx7i7RxG3x
A critical member of @IC_CADRE, Dr. Mary Vaughan-Sarrazin provides analysis to #HealthServicesResearch that informs many processes and protocols, especially in veterans care. Learn more: https://t.co/BxAMyr5jPy
Internal Medicine Grand Rounds, today, noon.
"Navigating new publication models without becoming prey: From Preprint Servers to Open-Access Journals"
@eliowa & Janna Lawrence @HardinLib
https://t.co/RojXg18nms